Movano (NASDAQ:MOVE) Raised to Hold at Wall Street Zen

Movano (NASDAQ:MOVE) was upgraded by investment analysts at Wall Street Zen to a “hold” rating in a report released on Saturday.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Movano in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Movano Price Performance

MOVE stock opened at $8.39 on Friday. The stock has a market capitalization of $6.96 million, a P/E ratio of -0.77 and a beta of 0.77. Movano has a 1-year low of $4.67 and a 1-year high of $62.80. The business has a fifty day moving average price of $8.47 and a 200-day moving average price of $7.47.

Movano (NASDAQ:MOVE) last released its quarterly earnings data on Friday, November 14th. The technology company reported ($4.73) EPS for the quarter, beating the consensus estimate of ($7.00) by $2.27. Movano had a negative return on equity of 647.91% and a negative net margin of 3,409.60%.The company had revenue of $0.08 million for the quarter, compared to analysts’ expectations of $3.88 million.

Hedge Funds Weigh In On Movano

Several institutional investors have recently made changes to their positions in MOVE. Citadel Advisors LLC purchased a new position in shares of Movano in the third quarter worth approximately $28,000. Baird Financial Group Inc. raised its position in Movano by 3.6% in the first quarter. Baird Financial Group Inc. now owns 323,943 shares of the technology company’s stock worth $593,000 after acquiring an additional 11,366 shares during the period. Finally, Clayton Partners LLC boosted its stake in shares of Movano by 27.2% during the 1st quarter. Clayton Partners LLC now owns 143,476 shares of the technology company’s stock worth $263,000 after acquiring an additional 30,708 shares during the last quarter. Institutional investors own 16.64% of the company’s stock.

Key Stores Impacting Movano

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Shareholders approved key amendments and initiatives at the recent meeting, removing a source of corporate uncertainty and enabling planned corporate actions (capital-structure or governance changes). Investors often view such approvals as clearing the way for financings or restructurings that can stabilize a micro-cap name. Movano stockholders approve key amendments and initiatives
• Neutral Sentiment: Recent analyst / media write-ups are re-examining Movano’s outlook vs. peers, highlighting valuation and business-model questions but not issuing widespread upgrades — coverage that can attract attention but is unlikely on its own to sustain a rally. Analyzing Movano (NASDAQ:MOVE) and Health Catalyst (NASDAQ:HCAT)
• Negative Sentiment: Fundamentals remain challenging: recent quarterly results showed a smaller-than-expected EPS loss relative to estimates but revenue was extremely low and the company continues to report large operating losses and negative margins — factors that keep upside speculative until revenue and cash-flow trajectories improve.
• Negative Sentiment: Market structure risk — Movano has a very small market capitalization, low average daily volume and a wide range between its 52-week low and high. That combination makes the stock prone to outsized moves on limited news or low-volume trades, increasing short-term volatility and execution risk for investors.

About Movano

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.